{"help": "https://www.lcrdigitalcommons.com/km/api/3/action/help_show?name=datastore_search", "success": true, "result": {"include_total": true, "limit": 100, "records_format": "objects", "resource_id": "88594d2c-6c66-48d7-9626-dcc6bdc040cd", "total_estimation_threshold": null, "records": [{"_id":1,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KF86","PRIMARY_LEVEL_DESCRIPTION":"THE YOUNG LIVES FOUNDATION","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":2,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KG26","PRIMARY_LEVEL_DESCRIPTION":"MIND IN BRIGHTON & HOVE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":3,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KG30","PRIMARY_LEVEL_DESCRIPTION":"WASHINGTON MIND","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":4,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KH13","PRIMARY_LEVEL_DESCRIPTION":"PAT FRANKISH PSYCHOLOGY & PSYCHOTHERAPY CONSULTANCY LTD","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":5,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KH24","PRIMARY_LEVEL_DESCRIPTION":"INVICTUS WELLBEING SERVICES COMMUNITIES INTEREST COMPANY","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":6,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KH28","PRIMARY_LEVEL_DESCRIPTION":"HAVANT AND EAST HANTS MIND","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":7,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KH29","PRIMARY_LEVEL_DESCRIPTION":"MAXIMUS UK SERVICES LIMITED","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":8,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KH43","PRIMARY_LEVEL_DESCRIPTION":"TIME TO TALK WEST BERKSHIRE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":9,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KJ43","PRIMARY_LEVEL_DESCRIPTION":"PURE INNOVATIONS LIMITED","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":10,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KJ58","PRIMARY_LEVEL_DESCRIPTION":"YMCA NORFOLK","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":11,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KJ87","PRIMARY_LEVEL_DESCRIPTION":"MURRAY HALL COMMUNITY TRUST","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":12,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KK55","PRIMARY_LEVEL_DESCRIPTION":"CHAT YOUTH COUNSELLING","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":13,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KK62","PRIMARY_LEVEL_DESCRIPTION":"SALUS","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":14,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KM02","PRIMARY_LEVEL_DESCRIPTION":"BRATHAY TRUST","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":15,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KM33","PRIMARY_LEVEL_DESCRIPTION":"HEALTHBOX CIC","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":16,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KM44","PRIMARY_LEVEL_DESCRIPTION":"KIDS INSPIRE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":17,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KM57","PRIMARY_LEVEL_DESCRIPTION":"SOUTH EAST AND CENTRAL ESSEX MIND","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":18,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KM78","PRIMARY_LEVEL_DESCRIPTION":"GIPSIL LTD","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":19,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KN04","PRIMARY_LEVEL_DESCRIPTION":"ACTION FOR CHILDREN - STAFFS CC EHWS","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":20,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8KN05","PRIMARY_LEVEL_DESCRIPTION":"ACTION FOR CHILDREN - DERBY CC EHWS","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":21,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"8QW60","PRIMARY_LEVEL_DESCRIPTION":"ACHIEVING FOR CHILDREN - WINDSOR AND MAIDENHEAD","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":22,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"A344","PRIMARY_LEVEL_DESCRIPTION":"BHT SUSSEX","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":23,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"A3MH","PRIMARY_LEVEL_DESCRIPTION":"NORFOLK AND WAVENEY MIND","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":24,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"A680","PRIMARY_LEVEL_DESCRIPTION":"UNITED RESPONSE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":25,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"A8JX","PRIMARY_LEVEL_DESCRIPTION":"SOUTH YORKSHIRE HOUSING ASSOCIATION LIMITED","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":26,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"A9B9U","PRIMARY_LEVEL_DESCRIPTION":"GET CEREBRAL LIMITED","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":27,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"AD7","PRIMARY_LEVEL_DESCRIPTION":"BRENT, WANDSWORTH AND WESTMINSTER MIND","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":28,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"ADX","PRIMARY_LEVEL_DESCRIPTION":"NORTHPOINT WELLBEING LIMITED","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":29,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"ADX01","PRIMARY_LEVEL_DESCRIPTION":"NORTHPOINT WELLBEING LIMITED HQ","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":30,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"AHL","PRIMARY_LEVEL_DESCRIPTION":"INMIND HEALTHCARE - HEAD OFFICE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":31,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"AHY","PRIMARY_LEVEL_DESCRIPTION":"BRAMLEY HEALTH","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":32,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"ALR02","PRIMARY_LEVEL_DESCRIPTION":"BMHC-FTB","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":33,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"ALW03","PRIMARY_LEVEL_DESCRIPTION":"WESTON SAFE HAVEN","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":34,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"AMC05","PRIMARY_LEVEL_DESCRIPTION":"SELF HELP SERVICES (MANCHESTER)","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":35,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"AMC06","PRIMARY_LEVEL_DESCRIPTION":"SELF HELP SERVICES (TANDG)","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":36,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"AMD","PRIMARY_LEVEL_DESCRIPTION":"THE KALEIDOSCOPE PLUS GROUP","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":37,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"AMX8","PRIMARY_LEVEL_DESCRIPTION":"CARETECH COMMUNITY SERVICES (NO.2) LIMITED","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":38,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"AN38","PRIMARY_LEVEL_DESCRIPTION":"ACCOMPLISH GROUP LIMITED","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":39,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"ANN","PRIMARY_LEVEL_DESCRIPTION":"INTEGRATED COMMUNITY CARE LTD","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":40,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"AQMF","PRIMARY_LEVEL_DESCRIPTION":"KIDS","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":41,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"ATM01","PRIMARY_LEVEL_DESCRIPTION":"NEWBRIDGE CARE SYSTEMS","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":42,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"ATM02","PRIMARY_LEVEL_DESCRIPTION":"SCHOEN CLINIC YORK","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":43,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"AXJ","PRIMARY_LEVEL_DESCRIPTION":"PRE-SCHOOL LEARNING ALLIANCE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":44,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"B6P8H","PRIMARY_LEVEL_DESCRIPTION":"THE SPACE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":45,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"B9B1U","PRIMARY_LEVEL_DESCRIPTION":"PHASE TRUST","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":46,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"D3A8T","PRIMARY_LEVEL_DESCRIPTION":"TOWER HAMLETS EMOTIONAL WELL-BEING SERVICES (STRONGER FAMILIES)","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":47,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DA6","PRIMARY_LEVEL_DESCRIPTION":"BEACON COUNSELLING","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":48,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DD6","PRIMARY_LEVEL_DESCRIPTION":"MID AND NORTH ESSEX MIND","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":49,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DDF","PRIMARY_LEVEL_DESCRIPTION":"HULL AND EAST YORKSHIRE MIND","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":50,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DE8","PRIMARY_LEVEL_DESCRIPTION":"ELYSIUM HEALTHCARE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":51,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DFC","PRIMARY_LEVEL_DESCRIPTION":"KOOTH DIGITAL HEALTH LIMITED","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":52,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DGT","PRIMARY_LEVEL_DESCRIPTION":"THE BRANDON CENTRE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":53,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DL501","PRIMARY_LEVEL_DESCRIPTION":"CLINICAL PARTNERS","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":54,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DN7","PRIMARY_LEVEL_DESCRIPTION":"ELLERN MEDE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":55,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DNE","PRIMARY_LEVEL_DESCRIPTION":"COMPASS","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":56,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DPV","PRIMARY_LEVEL_DESCRIPTION":"CHUMS CIC","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":57,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DRL","PRIMARY_LEVEL_DESCRIPTION":"42ND STREET","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":58,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DT9","PRIMARY_LEVEL_DESCRIPTION":"THE WHAT CENTRE LIMITED","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":59,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DV503","PRIMARY_LEVEL_DESCRIPTION":"BRADFORD THERAPEUTIC SERVICES","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":60,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DV504","PRIMARY_LEVEL_DESCRIPTION":"LEICESTER POST SEXUAL ABUSE SERVICE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":61,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DV7","PRIMARY_LEVEL_DESCRIPTION":"OFF THE RECORD YOUTH COUNSELLING","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":62,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DWH","PRIMARY_LEVEL_DESCRIPTION":"OPTIONS FOR CARE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":63,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DWW","PRIMARY_LEVEL_DESCRIPTION":"ACTIVE PATHWAYS","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":64,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DXK","PRIMARY_LEVEL_DESCRIPTION":"SOLUTIONS4HEALTH LTD","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":65,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DXY01","PRIMARY_LEVEL_DESCRIPTION":"STEP 2 YOUNG PEOPLE'S HEALTH (TONG STREET)","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":66,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY005","PRIMARY_LEVEL_DESCRIPTION":"BARNARDO'S LISTER HILLS BRADFORD","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":67,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY006","PRIMARY_LEVEL_DESCRIPTION":"BARNARDO'S HAMPSHIRE SPECIALIST PARENTING SUPPORT SERVICE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":68,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY008","PRIMARY_LEVEL_DESCRIPTION":"BARNARDOS THE HAVEN","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":69,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY009","PRIMARY_LEVEL_DESCRIPTION":"SWINDON TRAILBLAZER","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":70,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY00A","PRIMARY_LEVEL_DESCRIPTION":"ISLINGTON MENTAL HEALTH SERVICE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":71,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY00B","PRIMARY_LEVEL_DESCRIPTION":"BARNARDO'S ORCHARD MOSAIC","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":72,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY00C","PRIMARY_LEVEL_DESCRIPTION":"BARNARDO'S ISLE OF WIGHT TALK 2 SERVICE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":73,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY00D","PRIMARY_LEVEL_DESCRIPTION":"BARNARDO'S ISLE OF WIGHT ADHD SUPPORT SERVICE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":74,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY00E","PRIMARY_LEVEL_DESCRIPTION":"BARNARDO'S HARROW HORIZONS","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":75,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY00F","PRIMARY_LEVEL_DESCRIPTION":"BARNARDO'S MYTIME CUMBRIA","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":76,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY00H","PRIMARY_LEVEL_DESCRIPTION":"EARLY HELP WILTSHIRE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":77,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY00I","PRIMARY_LEVEL_DESCRIPTION":"SOUTH MENTAL HEALTH SUPPORT TEAM - CUMBRIA","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":78,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"DY00J","PRIMARY_LEVEL_DESCRIPTION":"YOUNG PERSON'S SOCIAL PERSCRIBING SERVICE - CUMBRIA","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":79,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"E2B0X","PRIMARY_LEVEL_DESCRIPTION":"EAST SUSSEX SWIFT","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":80,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"F0S5O","PRIMARY_LEVEL_DESCRIPTION":"MARY FRANCES TRUST","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":81,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"G5A9J","PRIMARY_LEVEL_DESCRIPTION":"MHST ISLE OF WIGHT","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":82,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"G5N0R","PRIMARY_LEVEL_DESCRIPTION":"STANDGUIDE GROUP","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":83,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"G8M2Q","PRIMARY_LEVEL_DESCRIPTION":"NO5 YOUNG PEOPLE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":84,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"GA4","PRIMARY_LEVEL_DESCRIPTION":"INVOLVE KENT","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":85,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"GAJ01","PRIMARY_LEVEL_DESCRIPTION":"YOUNG SOMERSET (EDINGTON)","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":86,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"GED02","PRIMARY_LEVEL_DESCRIPTION":"MILL LODGE HOSPITAL","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23a","MEASURE_NAME":"Referrals on EIP pathway entering treatment","MEASURE_VALUE":"*"},{"_id":87,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"H7L3O","PRIMARY_LEVEL_DESCRIPTION":"GADDUM CENTRE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":88,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"I9X1F","PRIMARY_LEVEL_DESCRIPTION":"CHESHIRE AND MERSEYSIDE RESILIENCE HUB","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":89,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"J5J5Z","PRIMARY_LEVEL_DESCRIPTION":"CHANGE BRIEF THERAPY LTD","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":90,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"J6X2R","PRIMARY_LEVEL_DESCRIPTION":"CARALINE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":91,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"J8F1X","PRIMARY_LEVEL_DESCRIPTION":"KENT & MEDWAY SAFE HAVENS","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":92,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"K7L8M","PRIMARY_LEVEL_DESCRIPTION":"PIE FACTORY MUSIC","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":93,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"L1Y6E","PRIMARY_LEVEL_DESCRIPTION":"SURREY WELLBEING PARTNERSHIP","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":94,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"L4B5N","PRIMARY_LEVEL_DESCRIPTION":"ST HELEN'S RESILIENCE SERVICE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":95,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"L9P5I","PRIMARY_LEVEL_DESCRIPTION":"THE EMPLOYEE RESILIENCE COMPANY LTD","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":96,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"M0L1I","PRIMARY_LEVEL_DESCRIPTION":"CHILDREN AND YOUNG PEOPLES EMPOERMENT PROJECT (CHILYPEP)","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":97,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"NFG","PRIMARY_LEVEL_DESCRIPTION":"MIND CENTRE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":98,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"NFJ","PRIMARY_LEVEL_DESCRIPTION":"ST MATTHEWS HEALTHCARE","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":99,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"NI328","PRIMARY_LEVEL_DESCRIPTION":"WE ARE WITH YOU IN CORNWALL TRURO","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"},{"_id":100,"REPORTING_PERIOD_START":"2023-01-01T00:00:00","REPORTING_PERIOD_END":"2023-03-31T00:00:00","STATUS":"Final","BREAKDOWN":"Provider","PRIMARY_LEVEL":"NI398","PRIMARY_LEVEL_DESCRIPTION":"WE ARE WITH YOU IN CANTERBURY & COASTAL","SECONDARY_LEVEL":"NONE","SECONDARY_LEVEL_DESCRIPTION":"NONE","MEASURE_ID":"EIP23b","MEASURE_NAME":"Referrals on EIP pathway entering treatment within two weeks","MEASURE_VALUE":"*"}], "fields": [{"id": "_id", "type": "int"}, {"id": "REPORTING_PERIOD_START", "type": "timestamp", "info": {"type_override": "timestamp"}}, {"id": "REPORTING_PERIOD_END", "type": "timestamp", "info": {"type_override": "timestamp"}}, {"id": "STATUS", "type": "text"}, {"id": "BREAKDOWN", "type": "text"}, {"id": "PRIMARY_LEVEL", "type": "text"}, {"id": "PRIMARY_LEVEL_DESCRIPTION", "type": "text"}, {"id": "SECONDARY_LEVEL", "type": "text"}, {"id": "SECONDARY_LEVEL_DESCRIPTION", "type": "text"}, {"id": "MEASURE_ID", "type": "text"}, {"id": "MEASURE_NAME", "type": "text"}, {"id": "MEASURE_VALUE", "type": "text"}], "_links": {"start": "/api/action/datastore_search?resource_id=88594d2c-6c66-48d7-9626-dcc6bdc040cd", "next": "/api/action/datastore_search?resource_id=88594d2c-6c66-48d7-9626-dcc6bdc040cd&offset=100"}, "total": 10315, "total_was_estimated": false}}